Dr. Yurgelun is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
450 Brookline Ave
Boston, MA 02215Phone+1 617-632-6835
Education & Training
- Beth Israel Deaconess Medical CenterFellowship, Hematology and Medical Oncology, 2009 - 2012
- Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 2006 - 2009
- Columbia University Vagelos College of Physicians and SurgeonsClass of 2006
Certifications & Licensure
- FL State Medical License 2022 - Present
- MA State Medical License 2009 - 2026
- ME State Medical License 2023 - 2026
- NH State Medical License 2022 - 2026
- RI State Medical License 2022 - 2026
- VT State Medical License 2022 - 2026
- CT State Medical License 2022 - 2025
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Systematic Hereditary Pancreatic Cancer Risk Assessment and Implications for Personalized Therapy Start of enrollment: 2017 Feb 24
Publications & Presentations
PubMed
- 99 citationsRecent progress in Lynch syndrome and other familial colorectal cancer syndromes.Patrick McKay Boland, Matthew B. Yurgelun, C. Richard Boland
CA. 2018-02-27 - 11 citationsRisk assessment and genetic counseling for Lynch syndrome - Practice resource of the National Society of Genetic Counselors and the Collaborative Group of the Americas...Spring Holter, Michael J Hall, Heather Hampel, Kory Jasperson, Sonia S Kupfer
Journal of Genetic Counseling. 2022-06-01 - 97 citationsNCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 1.2021.Jennifer M. Weiss, Samir Gupta, Carol A. Burke, Lisen Axell, Lee-may Chen
Journal of the National Comprehensive Cancer Network. 2021-10-15
Journal Articles
- Germline Cancer Susceptibility Gene Variants, Somatic Second Hits, and Survival Outcomes in Patients with Resected Pancreatic CancerRichard F Dunne, Leona A Doyle, William C Hahn, Jason L Hornick, Andrea J Bullock, Sapna Syngal, Albert C Koong, Natalia Khalaf, Brian M Wolpin, Douglas A Rubinson, Da..., Nature
- Validation of a Targeted Next-Generation Sequencing Approach to Detect Mismatch Repair Deficiency in Colorectal AdenocarcinomaLynette M Sholl, Amitabh Srivastava, Neal I Lindeman, Matthew B Yurgelun, Fei Dong, Nature
Lectures
- Implementation of systematic genetic counseling (GC) and multigene germline testing (MGT) for pancreatic cancer (PC) patients (pts).ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/24/2020
- Improving cascade genetic testing for families with inherited pancreatic cancer (PDAC) risk: The GENetic Education, Risk Assessment and TEsting (GENERATE) study.ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/24/2020
- Improving cascade genetic testing for families with inherited pancreatic cancer (PDAC) risk: The genetic education, risk assessment and testing (GENERATE) study.2019 ASCO Annual Meeting - 6/1/2019
- Join now to see all
Press Mentions
- Starch Supplement Reduces the Risk of Some Hereditary CancersJuly 26th, 2022
- Daily Aspirin Reduced CRC Risk in Lynch Syndrome PatientsJune 19th, 2020
- Therapy-Associated Polyposis May Mimic Hereditary CRC Symptoms in AYA Cancer SurvivorsFebruary 20th, 2020
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: